New Delhi, February 21: In a significant push to India’s pharmaceutical innovation landscape, the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India Pvt. Ltd., while simultaneously launching Cohort 2 of the AMRITVA programme to accelerate research commercialization. Industry-Academia Collaboration…
RamRajya News
Heralding RamRajya in Bharat